Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06736171 · ClinicalTrials.gov registry record · NA
Post Stroke Ambulation Recovery Using Robotic Exoskeletons
A NA study of Hemiparesis After Stroke, sponsored by Kessler Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 96
- Enrollment target
- 1
- Study location
NCT06736171: Recruiting NA study of Hemiparesis After Stroke, sponsored by Kessler Foundation.
NCT06736171 is a NA study of Hemiparesis After Stroke that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06736171, a NA study of Hemiparesis After Stroke, is actively recruiting participants, sponsored by Kessler Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate and compare different robotic exoskeletons (RE) and identify which is most appropriate for gait training for each patient based off their specific needs. This will help guide clinicians in prescribing the appropriate RE for rehabilitation.
Primary Outcome
10 meter walk test to evaluate walking speed after stroke and in response to the intervention.
Conditions Studied
Interventions
- DEVICE Robotic Exoskeleton
- OTHER SOC
Study Locations (1)
New Jersey
- Kessler Foundation - West Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2025-05-15 |
| Est. Completion | 2030-06 |
| Phase | NA |
What NCT06736171 shows while recruiting
NCT06736171 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Hemiparesis After Stroke appearing as the primary indexed condition, and to 2 interventions - of which Robotic Exoskeleton is the first listed.
NCT06736171 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06736171 about?
NCT06736171 is a clinical study titled "Post Stroke Ambulation Recovery Using Robotic Exoskeletons". The purpose of this research study is to evaluate and compare different robotic exoskeletons (RE) and identify which is most appropriate for gait training for each patient based off their specific needs. This will help guide clinicians in prescribing the appropriate RE for rehabilitation.
What is the current status of trial NCT06736171?
This trial is currently recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2025-05-15. Estimated completion is 2030-06.
What conditions does trial NCT06736171 study?
This clinical trial studies the following conditions: Hemiparesis After Stroke.
What interventions are being tested in trial NCT06736171?
The interventions under investigation include: Robotic Exoskeleton (DEVICE), SOC (OTHER).
Who is sponsoring clinical trial NCT06736171?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06736171 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemiparesis After Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06736171's enrollment target sits among peer trials
96 926th of 2000 higher than 1,070 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI